Skip to main content

Utilization of Ibrexafungerp in Pregnant Patients: An Updated Descriptive Analysis in TriNetX

    Basic Details
    Date Posted
    Medical Product

    This query is part of ongoing active monitoring activities for ibrexafungerp. This query aims to identify early signaling of ibrexafungerp use in pregnant patients.

    The study period includes data from June 1, 2020 to December 22, 2022 and contains data from 75 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network. We ran this query on January 19, 2023.

    Additional Details
    FDA Center
    Time Period
    June 1, 2020 – December 22, 2022
    Analysis Type
    TriNetX Analysis
    Population / Cohort
    Females 15 years of age and older
    Data Sources
    TriNetX USA Network